The founders behind the dire wolf and the defense-tech boom have a joint venture, and it has fur. Warhound, a Dallas-based defense technology company conceived by Colossal Biosciences CEO Ben Lamm and Anduril co-founder Palmer Luckey, came out of stealth on Thursday, October 22 with a $200 million seed round at a reported $1.2 billion valuation. The plan: clone and genetically enhance elite working dogs for the U.S. military, law enforcement and first responders, then wrap them in Anduril’s battlefield gear.
Key takeaways
- Warhound emerged from stealth October 22 with a $200 million seed round; Axios reports the valuation at $1.2 billion.
- The company was conceived by Colossal Biosciences’ Ben Lamm and Anduril’s Palmer Luckey. Luckey is a partner but owns no equity, Lamm told TechCrunch.
- CEO is David Spirk, a Marine Corps veteran and the Pentagon’s former chief data officer.
- Warhound says more than 80% of U.S. military working dogs come from Europe, and fewer than half are fit for service.
- Backers include In-Q-Tel, Sequoia Capital, ARK Invest, Franklin Templeton, 8VC and Lux Capital, among others.
The supply-chain problem with four legs
The U.S. military’s oldest autonomous system has a sourcing issue. According to the company, the military working dog program fields more than 2,200 dog teams, and more than 80% of those dogs are bought from Europe. Lamm has cited a Senate Armed Services Committee warning that the cost of procuring military working dogs from Europe is “skyrocketing” because of a finite number of overseas breeders and rising demand, per Fortune.
Warhound’s answer is vertical integration: biobank genetic material from top-performing American service dogs, use Colossal’s cloning and gene-editing platform to produce dogs with controlled delivery, then train and equip them domestically. Wired reports the company has already collected cell samples from elite military, police and first-responder dogs, mostly Belgian Malinois with some Labradors and shepherds, and has begun editing genes, starting with health problems that commonly cut careers short, such as hip dysplasia.
The dogs themselves do not exist yet. When they do, the company expects them to take on work that is dangerous for humans and difficult for machines: bomb detection, searches and other specialized operations, per TechCrunch.
The celebrity-founder pairing
Lamm is the billionaire CEO of Colossal Biosciences, the de-extinction company that announced gene-edited wolf pups it describes as dire wolves and is working to resurrect the woolly mammoth. Forbes reports private investors valued Colossal at $11.5 billion in 2025. Luckey founded Anduril, the defense technology company behind autonomous weapons systems and the Eagle Eye mixed-reality helmet.
The ownership split is unusual. Luckey is a partner in Warhound but holds no equity in it, Lamm told TechCrunch. Colossal owns equity and supports the company by licensing its technology. Day-to-day leadership falls to Spirk.
“Man’s best friend deserves man’s best tech,” Luckey said in a statement, per Forbes.
What Anduril brings
Every Warhound dog will ship with Anduril hardware and software: protective vests, goggles, sensors and battlefield situational-awareness systems, including what Forbes describes as a canine companion to the Eagle Eye helmet. Lamm has described vests with data sensors that feed information back to handlers so they can better understand what the dog is encountering.
The money
The $200 million seed is an unusually large round for a company whose product has not yet been born. The investor list, per the launch release, includes In-Q-Tel (a venture firm backed by the CIA and other U.S. intelligence agencies, per TechCrunch), Sequoia Capital, ARK Invest, Franklin Templeton, 8VC, USIT, Bob Nelsen, Breyer Capital, CAZ Investments, Neogenesis, Builders VC and Lux Capital.
Warhound does not yet know what it will charge per dog. It expects to sell to first responders, the Defense Department and military service groups.
The open questions
The science is the risk. Experts told Scientific American that what Warhound proposes is possible but prone to error, inefficiencies and ethical concerns, and cloning remains an inefficient process. There is also no product yet: the $1.2 billion valuation rests on a biobank, a license and a plan.
What to watch
- First cloned or gene-edited litters and any health-screening data Warhound releases.
- Whether Anduril’s canine kit ships as a standalone product for existing working dogs.
- Pricing and the first government contracts.
FAQ
What is Warhound?
A Dallas-based defense technology company, conceived by Colossal Biosciences CEO Ben Lamm and Anduril co-founder Palmer Luckey, that plans to clone and genetically enhance working dogs for the U.S. military, law enforcement and first responders.
How much did Warhound raise and at what valuation?
A $200 million seed round announced October 22, 2026. Axios reports a $1.2 billion valuation.
Who runs Warhound?
CEO David Spirk, a Marine Corps veteran and the Pentagon’s former chief data officer. Luckey is a partner without equity; Colossal owns equity and licenses its genetics platform to the company.
More funding news: Tractian raises $130M Series D for factory-floor AI.
